At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 16 enrolled
Drug / intervention
MT-1186drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Pharmacology Study of Oral Edaravone in Healthy Adult Subjects (Food Effect Study)
In Brief
A Phase 1 clinical trial evaluating MT-1186 for Healthy Adult Subjects. Completed, enrolled 16 participants across 1 site.
Detailed Summary
To evaluate the effect of food on the pharmacokinetics of oral edaravone in healthy adult subjects. In this study, we determined 5 different dietary conditions including 4 different meal contents and fasting condition.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy Adult Subjects
CountriesJapan
Collaborators--
Timeline
Phase 1CompletedFinished
2020202120222023202420252026
Enrollment StartJun 2019
Primary CompletionJul 2019
First PostedApr 2022
TodayJul 2026
First PostedApr 22, 2022
Enrollment StartJun 10, 2019
Primary CompletionJul 24, 2019
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 4.2 years ago
Interventions
MT-1186drug
A crossover study in which Japanese healthy subjects receive a single dose of MT-1186 under several dosing condition on Day 1, 3, 5, 7 and 24 according to their treatment sequence.